Mar. 31 at 12:15 PM
$PALI $SGMO $ANNX $PROP
Good morning, investors. Selective resilience is emerging, with biotech acting as a defensive growth pocket while industrials benefit from rising equipment demand and borrowing trends. On the watchlist,
$PALI trades near
$1.78 after positive Phase 1b data.
$SGMO remains a speculative biotech with potential FDA acceleration.
$ANNX is focused on complement diseases with late 2026 catalysts, while
$PROP sits near
$1.99 with leadership changes and upcoming earnings.
Read the full Analytica Alpha 👇
https://analyticainvestor.beehiiv.com/p/defense-and-energy-lead-flows
